(Feb. 21, 2025) – Study Examines Trends in Treatment for Substance Use Disorders
Despite the profound consequences of substance use disorders, treatment rates remain critically low. The prevalence of individuals who needed SUD treatment increased from 8.2 percent in 2013 to 17.1 percent in 2023. Additionally, the percentage of individuals receiving treatment dropped from 9.3 percent in 2013 to just 6.5 percent in 2020.
An article entitled, Trends in Treatment Need and Receipt for Substance Use Disorders in the US, published in JAMA Network Open discusses these statistics, what might be driving these trends and how health care providers can continue to support these patients appropriately.
HRSA Accepting Grant Applications for Rural Residency Planning and Development Program
The Health Resources and Services Administration is accepting grant applications for the Rural Residency Planning and Development program through Thursday, April 10. This program supports the creation of accredited rural residency programs to train more physicians in rural areas and address workforce shortages.
The RRPD also provides startup funding to help establish sustainable programs through stable funding sources like Medicare and Medicaid. The program will fund as much as $750,000 to eligible applicants.
MLN Connects Provider eNews Available
The Centers for Medicare & Medicaid Services issued the following updates to MLN Connects Provider eNews:
Before You Go ...
- Buprenorphine is the gold standard for the treatment of opioid use disorder, reducing mortality by more than 50 percent. Any provider in the United States can prescribe buprenorphine; however, prescribing numbers remain low. The authors of a study published in JAMA Open Network discuss the pros and cons of low-dose initiation.